Breaking Through Resistance: A Comparative Review of New Beta-Lactamase Inhibitors (Avibactam, Vaborbactam, Relebactam) Against Multidrug-Resistant Superbugs.

Antibiotics (Basel) · 2025 · PMC12108312 · PMID 40426594

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

MER-VAB also showed a trend toward lower Clostridioides difficile infection incidence, although this was not statistically significant.

also in 53,322 other papers

an increasing trendno p-value reported

NDM-producing strains, while less prevalent, have been identified across Europe, and have shown an increasing trend in the last years and are often linked to patients with prior healthcare exposure in endemic regions [ 10 , 15 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.